Scenarios that move TNDM
Tandem Diabetes Care, Inc. - Common Stock
Scenarios that move TNDM: 4 analyses, 1 positive, 3 negative.
- · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▼ · impact -45 · confidence low · horizon quarters
- · Beta Bionics stock plunges 37% after safety issues emerge — ▲ · impact +55 · confidence high · horizon weeks
- · ◇ What if… Oral GLP-1 drugs replace injectable treatments — ▼ · impact -35 · confidence low · horizon quarters
- · Beta Bionics prices public offering of stock and warrants — ▼ · impact -39 · confidence medium · horizon quarters